(2R,3R,4R,5R,6R)-methyl 5-acetamido-4-amino-6-((1R,2R)-1,2-dihydroxy-3-(octyloxycarbonyloxy)propyl)-2,3-difluorotetrahydro-2H-pyran-2-carboxylate

ID: ALA3426116

Chembl Id: CHEMBL3426116

PubChem CID: 118736935

Max Phase: Preclinical

Molecular Formula: C21H36F2N2O9

Molecular Weight: 498.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCOC(=O)OC[C@@H](O)[C@@H](O)[C@@H]1O[C@@](F)(C(=O)OC)[C@H](F)[C@H](N)[C@H]1NC(C)=O

Standard InChI:  InChI=1S/C21H36F2N2O9/c1-4-5-6-7-8-9-10-32-20(30)33-11-13(27)16(28)17-15(25-12(2)26)14(24)18(22)21(23,34-17)19(29)31-3/h13-18,27-28H,4-11,24H2,1-3H3,(H,25,26)/t13-,14-,15-,16-,17-,18-,21-/m1/s1

Standard InChI Key:  OQRDNOBXBWGLQO-VAMIYIBTSA-N

Alternative Forms

  1. Parent:

    ALA3426116

    ---

Associated Targets(non-human)

Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.52Molecular Weight (Monoisotopic): 498.2389AlogP: 0.63#Rotatable Bonds: 13
Polar Surface Area: 166.64Molecular Species: NEUTRALHBA: 10HBD: 4
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.67CX Basic pKa: 7.67CX LogP: 1.39CX LogD: 0.93
Aromatic Rings: Heavy Atoms: 34QED Weighted: 0.21Np Likeness Score: 0.66

References

1. Arns S, Tan J, Sun S, Galey A, Zisman N, Ross F, Udechukwu J, Dercho S, Gusti V, Paquette J, Webb M, Bourque E, Withers SG, Liggins R..  (2015)  Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay.,  25  (12): [PMID:25980910] [10.1016/j.bmcl.2015.04.059]

Source